IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
about
F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammationThe clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to manTear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating proceduresThe core mechanism of dry eye disease is inflammation.Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.Gene delivery in salivary glands: from the bench to the clinicAltered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.The important role of T cells and receptor expression in Sjögren's syndrome.Sjögren's syndrome: studying the disease in mice.The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus.Mouse Models of Primary Sjogren's Syndrome.IL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.IL-22 regulation of functional gene expression in salivary gland cells.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's SyndromeAnimal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1% methylprednisolone.Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome.Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.T Helper 17 Cells in Primary Sjögren's Syndrome.Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.New Murine Model of Early Onset Autoimmune Thyroid Disease/Hypothyroidism and Autoimmune Exocrinopathy of the Salivary Gland.Adult stem cells and tissue engineering strategies for salivary gland regeneration: a reviewBisphosphonates-related osteonecrosis of the jaws: a preliminary study of salivary interleukins.Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice.Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.Retroductal Nanoparticle Injection to the Murine Submandibular Gland.
P2860
Q24337221-84108B25-6252-4D4A-8A99-30540CD73C48Q26825196-C2F8E106-CD73-4751-9714-07E2CD68B9DAQ28393435-D7841C53-F7ED-4176-9202-32158F3EDC64Q34510429-BE664852-2D1C-4F15-9832-2A11EC2FD495Q34984739-31FAE4D7-4583-4E5C-896B-C74E764D208FQ35255990-C04F8D32-F253-4470-87D8-7225E62D3DD5Q35356313-6C50D808-DC95-41F5-B7F6-B3370F419845Q35535169-A33BF73B-9EC4-47E6-B833-D0D60AF1DF61Q35557789-7E23D1DA-172D-4236-83F8-C9E719948F20Q35579076-AC425A67-1A50-4D0F-BAEC-5D9B0B1EDE27Q35587450-CDBDF35E-033F-4C5F-A6F0-34B17129A3FCQ35923212-9E962A47-D0B9-41F7-BC11-3F9804054564Q36064302-9102FE41-9432-445B-853C-23A8D4BBDA82Q36652620-2625F16B-F76B-468E-BF3A-54D7F54A709EQ36957148-3651CE17-A2A3-4C8E-B33E-A1E241E44D8BQ37016308-6288160C-4315-4F01-9FEA-4E0C9A886770Q37418879-0405A128-EE3E-4A5E-821E-22C47D573534Q37497899-371F09CF-D0A3-4085-B5ED-0D87DDC5FAC0Q37501812-A1F67991-B711-41AF-BC14-C7106EF8ED7EQ37696996-7750BB96-6E45-4E5F-8E7D-0E2258509E19Q37733323-B8724C87-4CF1-4C55-998D-67AE79AA70C9Q38130904-16E67C70-8FBB-4934-98FD-7A1516694ED8Q38693137-ACCC51E7-DBC3-46E8-A44C-9D2E21DBCD10Q40354609-86C67E24-2162-4FA9-AD6C-75D603C7CAB1Q41012621-8D0A7ACE-B967-41D9-B4B8-2C344D7612CAQ42176563-A0A164DE-31F2-4506-9DBC-2D4A1B8FFD9CQ45211726-A0EC0C46-A94F-451B-AD27-AF05DA44238EQ51282774-FB8EA050-04C7-46EA-B9E5-58F78E15A088Q52668875-005ECEE2-6C60-45F0-8F06-560A957F330CQ54352730-4958DC3E-FA70-47B0-8938-5AD227ED58A8Q55044660-B0E774EE-948B-4CA4-BBEE-3B6D011521D2
P2860
IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@ast
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@en
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@nl
type
label
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@ast
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@en
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@nl
prefLabel
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@ast
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@en
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@nl
P2093
P2860
P1476
IL17: potential therapeutic ta ...... ovirus-mediated gene transfer.
@en
P2093
Ammon B Peck
Byung Ha Lee
Cuong Q Nguyen
Hongen Yin
John A Chiorini
P2860
P2888
P356
10.1038/LABINVEST.2010.164
P577
2010-09-20T00:00:00Z
P5875
P6179
1009934766